Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy

January 20, 2025 |  

Discover the key takeaways from OPEN Health’s latest whitepaper: “The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy.”

IRA whitepaper_OPEN Health

Discover the key takeaways from OPEN Health’s latest whitepaper The Potential Impact of the New Presidential Administration on the Future of the Inflation Reduction Act and Broader Healthcare Policy:

  • Review of President Trump’s healthcare policies during his first term: Attempts to repeal the Affordable Care Act (ACA), drug pricing initiatives, and Medicare and Medicaid policies.
  • A look into the future of the Inflation Reduction Act (IRA) and broader healthcare policy in the US: The potential impact of the incoming administration on the healthcare provisions of the IRA and other statements by President Trump focused on healthcare policy.

Read the full whitepaper to understand how these developments could influence healthcare decision-making and strategy. View the whitepaper here.

Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. Together we can unlock possibilities. For information about OPEN Health’s services and how we could support you, please get in touch. 

This content was provided by OPEN Health

Company Details

OPEN Health

OPEN Health

Email
Website

 Latest Content from  OPEN Health 

Delivering Medical Communications when travel is restricted: solving the 6 most common problems

Louise Carrington and Gemma Allen, OPEN Health

13th Edition – Spring MEDAFFAIRS Leaders Forum

OPEN VIE (Amanda Pulfer, Strategic Director and Sergio Diaz, Patient Centred Outcomes Consultant) were delighted to speak at the Medical Affairs Leaders Forum yesterday.

Keeping calm and carrying on: COVID-19 and approaches to CME/CPD during a viral outbreak

Celeste Kolanko, Managing Director, Liberum OPEN Health

Meet two of OPEN Health’s practices – Peloton Advantage and Pharmerit at MAPS 2020

Turning scientific knowledge and data into evidence

My Dad was ‘one in a million’​, as the saying goes. But actually he was one in 300 million (of patients worldwide with rare disease)

Emily Wigginton, Client Services Director, OPEN Health Patient & Brand Communications

Delivering change through better rare disease communications

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.

Equipping your medical affairs teams with solutions to navigate the healthcare landscape

Dr Tyler Ray, OPEN Health Medical Communications

CSR ‘Christmas Spirit’ 2019

OPEN Health champions CSR over Christmas by giving back to the community and increasing our  activities and efforts

Spotlight interview: 15 minutes on Independent Medical Education

Celeste Kolanko, Managing Director of Liberum, OPEN Health takes 15 minutes to answer some key questions on independent medical education.

OPEN Health supports Genetic Alliance UK’s Rare Film Festival!

OPEN Health joined a number of rare disease patients, patient groups and industry representatives at the Regent Street cinema in London to see the winners announced at the Rare Film…